Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

CGTX

$0.98-1.04%

COGNITION THERAPEUTICS INC

Market Cap
$94M
Sector
Materials
Industry
Pharmaceuticals
Beta
1.82
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.9x
buying
Congress
—
recent trades
Short Volume
44%
W/W -16.0pp

Market & Alt Data

News
8
recent articles
Activist
13D
BIOS
Analyst Consensus
Strong Buy
9 analysts
Velocity Score
24.85x
Current Rate (90d)
213.06/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-04-162026-04-20Doyle John BrendanChief Financial OfficerPurchase10.0K$1.13$11K627.5KView
2026-04-162026-04-20Ricciardi LisaDirector & CEO & PresidentPurchase9,175$1.10$10K1.72MView

Recent News

Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
Yahoo · 2026-09-08
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance · 2026-08-06
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
Yahoo Finance · 2026-08-06
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
Yahoo Finance · 2026-07-13

Informational purposes only, not investment advice.

Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%
Yahoo Finance · 2026-06-24
Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX)
Yahoo Finance · 2026-06-24
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
Yahoo Finance · 2026-06-16
Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?
Yahoo Finance · 2026-06-02

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 2
1 active trial